Saumil Oza is a Cardiology physician. OpenAlex indexes 54 publications with 961 citations (h-index 15); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1824 King Street
Suite 300
Jacksonville, FL 322044736
Telephone
904-388-1820Registry record last updated 2 Jun 2014.
Clinical trials
- Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
- Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation
Sponsor: Biosense Webster, Inc.
- Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF)
Sponsor: Biosense Webster, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biosense Webster, Inc.Program year202536 payments$35,689openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year202528 payments$23,931openpaymentsdata.cms.gov ↗
- GE HEALTHCAREProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
56.8%Beta blocker27.4%Metoprolol Tartrate37%Metoprolol Succinate33%Carvedilol16%Sotalol15%Part D≥58 patientsAntiarrhythmic13.7%Flecainide Acetate50%Amiodarone Hcl39%Multaq11%Part D<11 patients+ 9 more classes in this area
Blood & clotting
41.2%Factor Xa inhibitor36.6%Eliquis89%Xarelto11%Part D≥138 patientsVitamin K antagonist2.4%Warfarin Sodium68%Jantoven32%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
2%Proton pump inhibitor1%Pantoprazole Sodium100%Part D<11 patientsPotassium supplement1%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation
New England Journal of Medicine
2026 - Insights Into Early Adoption and Physician Learning Curve of Pulsed Field Ablation in the United States
Circulation Arrhythmia and Electrophysiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”